Fisher named executive director, research, business administration at Siteman

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nick Fisher was named executive director of research and business administration at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

Fisher now leads the fiscal and managerial administration of research facilities, information systems, human resources and day-to-day operations of Siteman. He has 14 years of experience with academic clinical research and cancer center operations and was selected after a national search.

Fisher has worked in the School of Medicine’s Division of Oncology and at Siteman Cancer Center since 2003. Since then, he has served in many positions, including director of operations, director of clinical research and manager of oncology clinical research.

YOU MAY BE INTERESTED IN

Last week, FDA granted accelerated approval to Replimune Group Inc. for it’s biologic, RP1 (vusolimogene oderparepvec), following the FDA Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login